News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,663 Results
Type
Article (26985)
Company Profile (73)
Press Release (358605)
Section
Business (106912)
Career Advice (527)
Deals (17412)
Drug Delivery (49)
Drug Development (49760)
Employer Resources (48)
FDA (12369)
Job Trends (8698)
News (190986)
Policy (19808)
Tag
Academia (1819)
Alliances (27331)
Alzheimer's disease (981)
Approvals (12349)
Artificial intelligence (104)
Bankruptcy (139)
Best Places to Work (7115)
Breast cancer (135)
Cancer (917)
Cardiovascular disease (80)
Career advice (479)
Cell therapy (152)
Clinical research (41126)
Collaboration (278)
Compensation (64)
COVID-19 (1562)
C-suite (64)
Data (997)
Diabetes (110)
Diagnostics (3463)
Earnings (37213)
Events (52506)
Executive appointments (251)
FDA (12904)
Funding (241)
Gene therapy (86)
GLP-1 (352)
Government (3070)
Healthcare (12442)
Infectious disease (1614)
Inflammatory bowel disease (69)
IPO (7212)
Job creations (1879)
Job search strategy (431)
Layoffs (167)
Legal (3682)
Lung cancer (151)
Lymphoma (64)
Manufacturing (80)
Medical device (12759)
Medtech (12762)
Mergers & acquisitions (10309)
Metabolic disorders (296)
Neuroscience (1203)
NextGen Class of 2024 (4075)
Non-profit (2879)
Northern California (924)
Obesity (172)
Opinion (75)
Parkinson's disease (69)
Patents (62)
People (34802)
Phase I (11897)
Phase II (17969)
Phase III (14511)
Pipeline (314)
Postmarket research (1694)
Preclinical (3892)
Radiopharmaceuticals (182)
Rare diseases (135)
Real estate (2891)
Regulatory (14073)
Research institute (1660)
Resumes & cover letters (66)
Southern California (782)
Startups (2173)
United States (8783)
Vaccines (317)
Weight loss (121)
Date
Last 7 days (350)
Last 30 days (1357)
Last 365 days (20678)
2024 (20594)
2023 (23617)
2022 (31695)
2021 (34018)
2020 (32986)
2019 (29033)
2018 (22266)
2017 (19375)
2016 (18540)
2015 (21610)
2014 (16363)
2013 (13562)
2012 (14671)
2011 (14936)
2010 (13491)
Location
Africa (370)
Arizona (92)
Asia (24694)
Australia (4021)
California (2026)
Canada (912)
China (216)
Colorado (111)
Connecticut (115)
Delaware (66)
Europe (48429)
Florida (333)
Georgia (90)
Illinois (262)
Indiana (161)
Kansas (67)
Maryland (458)
Massachusetts (1485)
Michigan (85)
Minnesota (196)
New Jersey (722)
New York (626)
North Carolina (432)
Northern California (924)
Ohio (92)
Pennsylvania (589)
South America (544)
Southern California (782)
Texas (348)
Utah (63)
Washington State (165)
385,663 Results for "alpha tau medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported first quarter 2024 financial results and provided a corporate update.
May 20, 2024
·
9 min read
Press Releases
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
December 6, 2024
·
1 min read
Press Releases
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 19, 2024
·
10 min read
Alpha Tau to Participate in May 2024 Investor Conferences
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.
May 1, 2024
·
1 min read
Alpha Tau to Present at the Jefferies Global Healthcare Conference
Alpha Tau Medical Ltd. today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Global Healthcare Conference on June 5 th , 2024.
May 21, 2024
·
1 min read
Press Releases
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 11, 2024
·
1 min read
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
Press Releases
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
December 18, 2024
·
5 min read
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
Alpha Tau Medical today the publication of an article entitled “Extended Follow-Up Outcomes from Pooled Prospective Studies Evaluating Efficacy of Interstitial Alpha Radionuclide Treatment for Skin and Head and Neck Cancers” in the journal Cancers, with further detail on data previously announced by the Company in August 2023.
June 25, 2024
·
7 min read
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the presentation of new preclinical data at the 2024 congress of the European Society for Radiotherapy and Oncology (ESTRO).
May 6, 2024
·
5 min read
1 of 38,567
Next
